Abstract
Purpose of this study was to compare bioactive glass and autogenous bone as a bone substitute material in tibial plateau fractures. We designed a prospective, randomized study consisting of 25 consecutive operatively treated patients with depressed unilateral tibial comminuted plateau fracture (AO classification 41 B2 and B3).14 patients (7 females, 7 males, mean age 57 years, range 25–82) were randomized in the bioglass group (BG) and 11 patients (6 females, 5 males, mean age 50 years, range 31–82) served as autogenous bone control group (AB). Clinical examination of the patients was performed at 3 and 12 months, patients’ subjective and functional results were evaluated at 12 months. Radiological analysis was performed preoperatively, immediately postoperatively and at 3 and 12 months. The postoperative redepression for both studied groups was 1 mm until 3 months and remained unchanged at 12 months. No differences were identified in the subjective evaluation, functional tests and clinical examination between the two groups during 1 year follow-up. We conclude that bioactive glass granules can be clinically used as filler material instead of autogenous bone in the lateral tibial plateau compression fractures.
This is a preview of subscription content, access via your institution.




References
Honkonen SE. Indications for surgical treatment of tibial condyle fractures. Clin Orthop Relat Res. 1994;302:199–205.
Tscherne H, Lobenhoffer P. Tibial plateau fractures. Management and expected results. Clin Orthop Relat Res. 1993;292:87–100.
Waddell JP, Johnston DW. Fractures of the tibial plateau: a review of ninety-five patients and comparison of treatment methods. J Trauma. 1981;21(5):376–81.
Cockin J. Autologous bone crafting-complications at the donor site. J Bone Joint Surg. 1971;53B(1):153.
Burri C, Bartzke G, Goldewey J, Muggler E. Fractures of the tibial plateau. Clin Orthop Relat Res. 1979;138:84–93.
Jupiter JB, Winters S, Sigman S, Lowe C, Pappas C, Ladd AL, Van Wagoner M, Smith ST. Repair of five distal radius fractures with an investigational cancellous bone cement: a preliminary report. J Orthop Trauma. 1997;11(2):110–6.
Kopylov P, Runnqvist K, Jonsson K, Aspenberg P. Norian SRS versus external fixation in redisplaced distal radial fractures. A randomized study in 40 patients. Acta Orthop Scand. 1999;70(1):1–5.
Bucholz RW, Carlton A, Holmes R. Interporous hydroxyapatite as a bone graft substitute in tibial plateau fractures. Clin Orthop Relat Res. 1989;240:53–62.
Suzuki K, Kurabayashi H. Efficiency of hydroxyapatite-tricalcium phosphate-composite (HAP–TCP) for bone defect of tibia fracture—comparison between HAP–TCP and autogenous iliac bone. In: Andersson ÖH, Happonen RP, Yli-Urpo A, editors. Bioceramics, vol. 7. Oxford: Butterworth-Heinemann Ltd; 1994. p. 435–40.
Stankewich CJ, Swiontkowski MF, Tencer AF, Yetkinler DN, Poser RD. Augmentation of femoral neck fracture fixation with an injectable calcium–phosphate bone mineral cement. J Orthop Res. 1996;14(5):786–93.
Andersson ÖH, Liu G, Karlsson KH, Niemi L, Miettinen J, Juhanoja J. In vivo behaviour of glasses in the SiO2–Na2O–CaO–P2O5–Al2O3–B2O3 system. J Mater Sci Mater Med. 1990;1:219–27.
Hench LL, Splinter RJ, Allen WC, et al. Bonding mechanism at the interface of ceramic prosthetic materials. J Biomed Mat Res Symp. 1971;N2(Part-1):117–43.
Heikkilä JT, Aho HJ, Yli-Urpo A, Happonen RP, Aho AJ. Bone formation in rabbit cancellous bone defects filled with bioactive glass granules. Acta Orthop Scand. 1995;66(5):463–7.
Leach JK, Kaigler D, Wang Z, Krebsbach PH, Mooney DJ. Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials. 2006;27(17):3249–55.
15. Hench LL, Andersson ÖH. Bioactive glasses. In: Hench LL, Wilson J, editors. An introduction to bioceramics. Singapore: Reed Healthcare Communications; 1993. pp. 41–62.
Heikkilä JT, Aho AJ, Yli-Urpo A, Andersson OH, Aho HJ, Happonen RP. Bioactive glass versus hydroxylapatite in reconstruction of osteochondral defects in the rabbit. Acta Orthop Scand. 1993;64(6):678–82.
Andersson ÖH, Liu G, Kangasniemi K, et al. Evaluation of the acceptance of glass in bone. J Mater Sci Mater Med. 1992;3:145–50.
Lindfors NC, Hyvönen P, Nyyssönen M, Kirjavainen M, Kankare J, Gullichsen E, Salo J. Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis. Bone. 2010;47:212–8.
Turunen T, Peltola J, Yli-Urpo A, Happonen RP. Bioactive glass granules as a bone adjunctive material in maxillary sinus floor augmentation. Clin Oral Implant Res. 2004;15(2):135–41.
Lindfors NC, Koski I, Heikkilä JT, Mattila K, Aho AJ. A prospective randomized 14-year follow-up study of bioactive glass and autogenous bone as bone graft substitutes in benign bone tumors. J Biomed Mater Res Appl Biomater. 2010;94:157–64.
Jallot E, Benhayoune H, Kilian L, Irigaray JL, Barbotteau Y, Balossier G, Bonhomme P. Dissolution kinetics, selective leaching, and interfacial reactions of a bioglass coating enriched in alumina. J Colloid Interface Sci. 2001;233(1):83–90.
Lindfors NC. Treatment of a recurrent aneurysmal bone cyst with bioactive glass in a child allows for good bone remodelling and growth. Bone. 2009;45(2):398–400.
Stoor P, Söderling E, Salonen JI. Antibacterial effects of a bioactive glass paste on oral micro organisms. Acta Odontol Scand. 1998;56(3):161–5.
Peltola M, Suonpää J, Aitasalo K, Varpula M, Yli-Urpo A, Happonen RP. Obliteration of the frontal sinus cavity with bioactive glass. Head Neck. 1998;20(4):315–9.
Aitasalo K, Suonpää J, Peltola M, et al. Behaviour of bioactive glass (S53P4) in human frontal sinus obliteration. In: Sedel L, Rey C, editors. Bioceramics, vol. 10. Cambridge: Elsevier Science Ltd; 1997. p. 429–32.
Wilson J, Clark AE, Douek E, et al. Clinical applications of Bioglass implants. In: Andersson ÖH, Happonen RP, Yli-Urpo A, editors. Bioceramics, vol. 7. Oxford: Butterworth-Heinemann Ltd; 1994. p. 415–22.
Aho AJ, Suominen E, Alanen A, Yli-Urpo A, Knuuti J, Aho HJ. Remodelling of the tibia after grafting of a large cavity with particulate bioactive glass–hydroxylapatite-case report on treatment of fibrous dysplasia with 13 years follow-up. Acta Orthop Scand. 2003;74(6):766–70.
Lindfors NC, Heikkilä JT, Koski I, Mattila K, Aho AJ. Bioactive glass and autogenous bone as bone graft substitutes in benign bone tumors. J Biomed Mater Res Appl Biomater. 2009;90:131–6.
Schatzker J, McBroom R, Bruce D. The tibial plateau fracture. The Toronto experience 1968–1975. Clin Orthop Relat Res. 1979;138:94–104.
Holzach P, Matter P, Minter J. Arthroscopically assisted treatment of lateral tibial plateau fractures in skiers: use of a cannulated reduction system. J Orthop Trauma. 1994;8(4):273–81.
Asik M, Cetik O, Talu U, Sozen YV. Arthroscopy-assisted operative management of tibial plateau fractures. Knee Surg Sports Traumatol Arthrosc. 2002;10(6):364–70.
Segur JM, Torner P, Garcia S, Combalia A, Ramon R. Use of bone allograft in tibial plateau fractures. Arch Orthop Trauma Surg. 1998;117(6-7):357–9.
Lasanianos N, Mouzopoulos G, Garnavos C. The use of freeze-dried cancelous allograft in the management of impacted tibial plateau fractures. Injury. 2008;39(10):1106–12.
Itokazu M, Matsunaga T, Ishii M, Kusakabe H, Wyni Y. Use of arthroscopy and interporous hydroxyapatite as a bone graft substitute in tibial plateau fractures. Arch Orthop Trauma Surg. 1996;115(1):45–8.
Lobenhoffer P, Gerich T, Witte F, Tscherne H. Use of an injectable calcium phosphate bone cement in the treatment of tibial plateau fractures: a prospective study of twenty-six cases with twenty-month mean follow-up. J Orthop Trauma. 2002;16(3):143–9.
Trenholm A, Landry S, McLaughlin K, Deluzio KJ, Leighton J, Trask K, Leighton RK. Comparative fixation of tibial plateau fractures using alpha-BSM, a calcium phosphate cement, versus cancellous bone graft. J Orthop Trauma. 2005;19(10):698–702.
Horstmann WG, Verheyen CC, Leemans R. An injectable calcium phosphate cement as a bone-graft substitute in the treatment of displaced lateral tibial plateau fractures. Injury. 2003;34(2):141–4.
Simpson D, Keating JF. Outcome of tibial plateau fractures managed with calcium phosphate cement. Injury. 2004;35(9):913–8.
Welch RD, Zhang H, Bronson DG. Experimental tibial plateau fractures augmented with calcium phosphate cement or autologous bone graft. J Bone Joint Surg Am. 2003;85-A(2):222–31.
Russell TA, Leighton RK. Alpha-BSM Tibial Plateau Fracture Study Group. Comparison of autogenous bone graft and endothermic calcium phosphate cement for defect augmentation in tibial plateau fractures. A multicenter, prospective, randomized study. J Bone Joint Surg Am. 2008;90(10):2057–61.
Aho AJ, Heikkilä JT. Bone substitutes and related materials in clinical orthopaedics. In: Phillips GO, von Versen R, editors. Advances in Tissue Banking, vol. 1. Singapore: World Scientific; 1997. p. 73–108.
Chan PS, Klimkiewicz JJ, Luchetti WT, Esterhai JL, Kneeland JB, Dalinka MK, Heppenstall RB. Impact of CT scan on treatment plan and fracture classification of tibial plateau fractures. J Orthop Trauma. 1997;11(7):484–9.
Morii T, Koshino T, Odaka T, et al. Roentgenological and histological observations of bone reaction of glass–ceramic beads in tibial metaphysis and fibular diaphysis of man. In: Vincenzini P, editor. Ceramics in Clinical Applications. Amsterdam: Elsevier; 1987. p. 361–8.
Acknowledgments
Sincere thanks to Biostatistician Hans Helenius, MSc., Head of the Department of Biostatistics, University of Turku, for his valuable help in organizing the statistical analysis of the data.
Author information
Authors and Affiliations
Corresponding author
Additional information
Paper selected for publication from the 23rd European Conference on Biomaterials, Tampere, Finland, September 2010.
Rights and permissions
About this article
Cite this article
Heikkilä, J.T., Kukkonen, J., Aho, A.J. et al. Bioactive glass granules: a suitable bone substitute material in the operative treatment of depressed lateral tibial plateau fractures: a prospective, randomized 1 year follow-up study. J Mater Sci: Mater Med 22, 1073–1080 (2011). https://doi.org/10.1007/s10856-011-4272-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10856-011-4272-0
Keywords
- Iliac Crest
- Bioactive Glass
- Plain Film
- Calcium Phosphate Cement
- Hydroxylapatite